French pharma company Cristers to use Adents serialisation solution

| By | Drug Marking, Drug Quality Control, serialisation

Adents (France), a leading provider of versatile and easily deployable serialisation and track & trace solutions, had its Adents Prodigi cloud serialisation solution chosen by pharmaceutical company Cristers (France) to ensure compliance with the EU Falsified Medicines Directive (FMD) and provide beyond-compliance ROI.

Jointly developed with Microsoft and powered by Azure, Adents Prodigi allows for secure data exchange and helps leverage the power of serialisation data to improve business practices.

Cristers markets generic and OTC products, and is a French Lab owned by a cooperative of pharmacists. Holding a marketing authorisation for more than 400 products, Cristers differentiates itself with clear and handy packaging to facilitate communication with patients.

While searching for a serialisation solution that would ensure compliance with the FMD, Cristers also sought a means of enabling easy exchange of serialisation data with its supply chain partners, including contract manufacturers and logistics providers. Additionally, Cristers wanted a solution that would aid in the onboarding of more than 30 European partners – including CMOs, vendors and third-party logistics providers – and facilitate connection with a diverse set of Levels 3 & 4 serialisation solutions.

Adents serialisation solutions are designed to help companies gain simplified speed to compliance with regulatory requirements. The Adents Prodigi cloud-based Level 4 traceability solution centrally manages regulatory requirements, provides an easy onboarding process to connect multiple trading partners, and facilitates significant business improvements by enabling companies to utilize the massive amounts of data generated during the serialisation and track & trace process.

SOURCE: adents
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.